Chronic pain is a prevalent condition with profound impacts on occupational performance and work ability. Substance use for pain management is common, involving both pain medications and other substances such as cannabis and alcohol. While work ability in persons with chronic pain has been studied, limited research examines how substance use influences work ability.
Objective
This scoping review aimed to summarize research on the impact of substance use on work ability in persons with chronic musculoskeletal pain to identify knowledge gaps and inform interventions.
Methods
A scoping review approach was employed. Keywords and databases were defined, followed by a comprehensive literature search. Studies were screened by title, abstract, and full text. Inclusion criteria focused on adults with chronic musculoskeletal pain, excluding pediatric and neuropathic pain populations.
Results
From 4903 identified studies, 3253 abstracts and 159 full texts were screened, yielding 53 relevant studies. Most originated from North America and Europe. Findings revealed a complex relationship between substance use and work ability. Opioid use was frequently associated with reduced work ability, increased absenteeism, and decreased likelihood of returning to work. Conversely, limited evidence suggested opioids and methadone could facilitate work ability in specific cases.
Conclusion
Substance use significantly affects the work ability of persons with chronic pain, often diminishing occupational performance and increasing absenteeism. Addressing these challenges necessitates integrative health and social strategies and further exploration of comprehensive, interprofessional interventions.
BreivikHCollettBVentafriddaV, et al.Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain2006; 10: 287–287.
2.
CimasMAyalaASanzB, et al.Chronic musculoskeletal pain in European older adults: cross-national and gender differences. Eur J Pain2018; 22: 333–345.
3.
SyMPReyesRCDRoraldoMAPNR, et al.Uncovering the lived experiences of Filipino drug recoverees towards occupational participation and justice through an interpretative phenomenological analysis. Scand J Occup Ther2021; 28: 457–470.
4.
ToddAMcNamaraCLBalajM, et al.The European epidemic: pain prevalence and socioeconomic inequalities in pain across 19 European countries. Eur J Pain2019; 23: 1425–1436.
5.
World Health Organization (WHO). International Classification of Diseases, Eleventh Revision (ICD-11). 2022.
6.
Gómez PenedoJMRubelJABlättlerL, et al.The complex interplay of pain, depression, and anxiety symptoms in patients with chronic pain: a network approach. Clin J Pain2020; 36: 249–259.
7.
BeemsterTTvan BennekomCAMvan VelzenJM, et al.Vocational rehabilitation with or without work module for patients with chronic musculoskeletal pain and sick leave from work: longitudinal impact on work participation. J Occup Rehabil [Internet]2020; 31: 72–83.
8.
KökeAJASmeetsRJEMSchreursKM, et al.Dutch dataset pain rehabilitation in daily practice: content, patient characteristics and reference data. Eur J Pain2017; 21: 434–444.
9.
MakrisUWeinreichMFraenkelL, et al.Restricting Back pain and subsequent disability in activities of daily living among community-living older adults. J Aging Health2018; 30: 1482–1494.
10.
GantschnigBEHeiglFLeuW, et al.Effectiveness of the Bern ambulatory interprofessional rehabilitation (BAI-Reha) programme for patients with chronic musculoskeletal pain: a cohort study. Swiss Medical Weekly [Internet]2017; 147: 1920. https://smw.ch/article/doi/smw.2017.14433
11.
DueñasMSalazarAde SolaH, et al.Limitations in activities of daily living in people with chronic pain: identification of groups using clusters analysis. Pain Pract2020; 20: 179–187.
12.
KroenkeKKrebsEEBairMJ. Pharmacotherapy of chronic pain: a synthesis of recommendations from systematic reviews. Gen Hosp Psychiatry2009; 31: 206–219.
13.
CampbellGHallWDPeacockA, et al.Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study. Lancet Public Health2018; 3: e341–e350.
14.
BrennanPLSchutteKKMoosRH. Pain and use of alcohol to manage pain: prevalence and 3-year outcomes among older problem and non-problem drinkers. Addiction2005; 100: 777–786.
15.
NielsenSLintzerisNBrunoR, et al.Benzodiazepine use among chronic pain patients prescribed opioids: associations with pain, physical and mental health, and health service utilization. Pain Medicine2015; 16: 356–366.
16.
OrhurhuVJPittelkowTPHootenWM. Prevalence of smoking in adults with chronic pain. Tob Induc Dis2015; 13: 17.
17.
LjungvallHRhodinAWagnerS, et al.My life is under control with these medications’: an interpretative phenomenological analysis of managing chronic pain with opioids. BMC Musculoskelet Disord2020; 21: 1–14.
18.
VallerandANowakL. Chronic opioid therapy for nonmalignant pain: the patient’s perspective. Part I-Life before and after opioid therapy. Pain Manag Nurs2009; 10: 165–172.
19.
LawMCBaumCMDunnW(eds). Measuring occupational performance: supporting best practice in occupational therapy. Third edition. Thorofare, NJ: SLACK Incorporated, 2017, p. 1.
20.
Canadian Association of Occupational Therapists. Enabling occupation: An occupational therapy perspective. Ottawa, Ontario: CAOT Publications ACE, 1997.
21.
MartinLMBlivenMBoisvertR. Occupational performance, self-esteem, and quality of life in substance addictions recovery. OTJR: Occup Ther J Res2008; 28: 81–88.
22.
MartinLMSmithMRogersJ, et al.Mothers in recovery: an occupational perspective. Occup Ther Int2011; 18: 152–161.
23.
MenezesALCRuzzi-PereiraA. Desempenho ocupacional de adolescentes usuárias de drogas/occupational performance of adolescents drug users. Cadernos Brasileiros de Terapia Ocupacional2019; 27: 754–764.
24.
KiepekNBeaganBPhelanS. Substance use to enhance occupational performance and experience: a critical interpretive synthesis/Uso de substâncias para melhorar o desempenho e a experiência ocupacional: uma síntese interpretiva crítica. Cadernos Brasileiros de Terapia Ocupacional2019; 27: 843–857.
25.
RobinsonJPDansieEJWilsonHD, et al.Attitudes and beliefs of working and work-disabled people with chronic pain prescribed long-term opioids. Pain Med2015; 16: 1311–1324.
26.
AndrewsNEStrongJMeredithPJ, et al.It’s very hard to change yourself”: an exploration of overactivity in people with chronic pain using interpretative phenomenological analysis. PAIN2015; 156: 1215–1231.
27.
KennedyMCCousinsGHenmanMC. Analgesic use by ageing and elderly patients with chronic non-malignant pain: a qualitative study. Int J Clin Pharm2017; 39: 798–807.
28.
NarainNLiuWNMahmoodZ, et al.Women’s perspectives related to occupational performance following participation in substance use recovery programs. Occup Ther Ment Health2018; 34: 61–74.
29.
VowlesKEMcEnteeMLJulnesPS, et al.Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis. PAIN2015; 156: 569–576.
30.
TurnerHNOliverJComptonP, et al.Pain management and risks associated with substance use: practice recommendations. Pain Manag Nurs2022; 23: 91–108.
31.
HesselstrandMSamuelssonKLiedbergG. Occupational therapy interventions in chronic pain – A systematic review. Occup Ther Int2015; 22: 183–194.
32.
RyanDABolandP. A scoping review of occupational therapy interventions in the treatment of people with substance use disorders. Ir J Occup Ther2021; 49: 104–114.
33.
AsabaEAldrichRMGabrielssonH, et al.Challenging conceptualisations of work: revisiting contemporary experiences of return to work and unemployment. J Occup Sci2021; 28: 81–94.
34.
Occupational therapy practice framework: domain and process—Fourth Edition. Am J Occup Ther. 2020; 74: 7412410010p1–87.
35.
ArkseyHO’MalleyL. Scoping studies: towards a methodological framework. Int J Soc Res Methodol2005; 8: 19–32.
36.
MunnZPetersMDJSternC, et al.Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Med Res Methodol2018; 18: 43.
37.
GantschnigBEBaldisseraAFriedliT. Impact of substance use on the workability among persons with chronic pain – A scoping review, https://osf.io/xgzbe/ (25 May 2023, cited 27 November 2024).
38.
LevacDColquhounHO’BrienKK. Scoping studies: advancing the methodology. Implementation Sci2010; 5: 69.
39.
PetersMDJMarnieCTriccoAC, et al.Updated methodological guidance for the conduct of scoping reviews. JBI Evidence Synthesis2020; 18: 2119–2126.
40.
TriccoACLillieEZarinW, et al.PRISMA Extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med2018; 169: 467–473.
41.
GraneheimUHLundmanB. Qualitative content analysis in nursing research: concepts, procedures and measures to achieve trustworthiness. Nurse Educ Today2004; 24: 105–112.
42.
BrownJKlapowJDoleysD, et al.Disease-Specific and generic health outcomes: a model for the evaluation of long-term intrathecal opioid therapy in noncancer low back pain patients. Clin J Pain1999; 15: 122–131.
43.
DoleysDMColetonMTutakU. Use of intraspinal infusion therapy with non-cancer pain patients: follow-up and comparison of worker’s compensation vs. Non-worker’s compensation patients. Neuromodulation1998; 1: 149–159.
44.
SandströmJ. Clinical and social factors in rehabilitation of patients with chronic low back pain. Scand J Rehabil Med1986; 18: 35–43.
45.
WillisKDDoleysDM. The effects of long-term intraspinal infusion therapy with noncancer pain patients: evaluation of patient, significant-other, and clinic staff appraisals. Neuromodulation1999; 2: 241–253.
46.
DershJMayerTGGatchelRJ, et al.Prescription opioid dependence is associated with poorer outcomes in disabling spinal disorders. Spine (Phila Pa 1976)2008; 33: 2219–2227.
47.
DuseGDaviàGWhitePF. Improvement in psychosocial outcomes in chronic pain patients receiving intrathecal morphine infusions. Anesth Analg2009; 109: 1981–1986.
48.
FranklinGMRahmanEATurnerJA, et al.Opioid use for chronic low back pain: a prospective, population-based study among injured workers in Washington state, 2002–2005. Clin J Pain2009; 25: 743–751.
49.
KidnerCLMayerTGGatchelRJ. Higher opioid doses predict poorer functional outcome in patients with chronic disabling occupational musculoskeletal disorders. J Bone Joint Surg Am2009; 91: 919–927.
50.
MaclarenJEGrossRTSperryJA, et al.Impact of opioid use on outcomes of functional restoration. Clin J Pain2006; 22: 392–398.
51.
MakPHKTsuiSLNgKFJ. Long-term therapy of chronic non-malignant pain with potent opioids in an active police officer. Can J Anaesth2002; 49: 575–578.
52.
NorrefalkJRLinderJEkholmJ, et al.A 6-year follow-up study of 122 patients attending a multiprofessional rehabilitation programme for persistent musculoskeletal-related pain. Int J Rehabil Res2007; 30: 9–18.
53.
RhodinAGrönbladhLNilssonLH, et al.Methadone treatment of chronic non-malignant pain and opioid dependence–a long-term follow-up. Eur J Pain2006; 10: 271–278.
54.
TrescotAMGlaserSEHansenH, et al.Effectiveness of opioids in the treatment of chronic non-cancer pain. Pain Physician2008; 11: S181–S200.
55.
VolinnEFargoJDFinePG. Opioid therapy for nonspecific low back pain and the outcome of chronic work loss. Pain2009; 142: 194–201.
56.
AndersonJTHaasARPercyR, et al.Chronic opioid therapy after lumbar fusion surgery for degenerative disc disease in a Workers’ compensation setting. Spine2015; 40: 1775–1784.
57.
BredeEMayerTGGatchelRJ. Prediction of failure to retain work 1 year after interdisciplinary functional restoration in occupational injuries. Arch Phys Med Rehabil2012; 93: 268–274.
58.
BusseJWMahmoodHMaqboolB, et al.Characteristics of patients receiving long-term opioid therapy for chronic noncancer pain: a cross-sectional survey of patients attending the pain management centre at Hamilton general hospital, Hamilton, Ontario. Can Med Assoc Open Access J2015; 3: E324–E330.
59.
ChangYP. Factors associated with prescription opioid misuse in adults aged 50 or older. Nurs Outlook2018; 66: 112–120.
60.
ChuangEGilENGaoQ, et al.Relationship between opioid analgesic prescription and unemployment in patients seeking acupuncture for chronic pain in urban primary care. Pain Med2019; 20: 1528–1533.
61.
DenawaYKurtzWConermannT. The social and functional implications of high- versus low-dose opioids on chronic non-cancer pain. Pain Physician2019; 22: 401–411.
62.
GebauerSSalasJScherrerJF, et al.Disability benefits and change in prescription opioid dose. Popul Health Manag2019; 22: 503–510.
63.
GeorgeJMMenonMGuptaP, et al.Use of strong opioids for chronic non-cancer pain: a retrospective analysis at a pain centre in Singapore. Singapore Med J2013; 54: 506–510.
64.
HaukkaEKaila-KangasLLuukkonenR, et al.Predictors of sickness absence related to musculoskeletal pain: a two-year follow-up study of workers in municipal kitchens. Scand J Work Environ Health2014; 40: 278–286.
65.
KhoJYGasparMPKanePM, et al.Prognostic variables for patient return-to-work interval following carpal tunnel release in a Workers’ compensation population. Hand (N Y)2017; 12: 246–251.
66.
LalicSBellJSGyllenstenH, et al.Trajectories of sickness absence and disability pension before and after opioid initiation for noncancer pain: a 10-year population-based study. Pain2019; 160: 1224–1233.
67.
MesasAEGonzálezADMesasCE, et al.The association of chronic neck pain, low back pain, and migraine with absenteeism due to health problems in Spanish workers. Spine (Phila Pa 1976)2014; 39: 1243–1253.
68.
MichaëlisCKristiansenMNorredamM. Quality of life and coping strategies among immigrant women living with pain in Denmark: a qualitative study. BMJ Open2015; 5: e008075.
69.
NguyenTHRandolphDCTalmageJ, et al.Long-term outcomes of lumbar fusion among workers’ compensation subjects: a historical cohort study. Spine (Phila Pa 1976)2011; 36: 320–331.
70.
O’DonnellJAAndersonJTHaasAR, et al.Preoperative opioid use is a predictor of poor return to work in Workers’ compensation patients after lumbar diskectomy. Spine (Phila Pa 1976)2018; 43: 594–602.
71.
SchiffMTakeuchiTFleischmannR, et al.Patient-reported outcomes of baricitinib in patients with rheumatoid arthritis and no or limited prior disease-modifying antirheumatic drug treatment. Arthritis Res Ther2017; 19: 08.
72.
TwillmanRKHemmenwayNPassikSD, et al.Impact of opioid dose reduction on individuals with chronic pain: results of an online survey. J Pain Res2018; 11: 2769–2779.
73.
UrquhartDMWlukaAEvan TulderM, et al.Efficacy of low-dose amitriptyline for chronic low back pain: a randomized clinical trial. JAMA Intern Med2018; 178: 1474–1481.
74.
WangXBorgmanBVertuaniS, et al.A systematic literature review of time to return to work and narcotic use after lumbar spinal fusion using minimal invasive and open surgery techniques. BMC Health Serv Res2017; 17: 46.
75.
AlvaradoAMChungEDeutschH. Effects of the 2016 CDC opioid prescription guidelines on opioid use and worker compensation case length in patients with back pain. Acta Neurochir2023; 165: 2139–2144.
76.
CalatayudJPerelló-RomeroLNúñez-CortésR, et al.The importance of a healthy lifestyle despite chronic pain: prospective cohort with 11-year register follow-up. Prev Med2024; 180: 107858.
77.
CatonLShortNGoetzingerA, et al.My goal is…to get through the day without pain”: a qualitative study on chronic pain experiences and treatment needs among child caregiving women. Matern Child Health J2024; 28: 1210–1218.
78.
DuhnPChristensenRLochtH, et al.Phenotypic characteristics of patients with chronic widespread pain and fibromyalgia: a cross-sectional cluster analysis. Scand J Rheumatol2024; 53: 325–334.
79.
FishmanMAAntonyABHunterCW, et al.The cost of lost productivity in an opioid utilizing pain sample. J Pain Res2021; 14: 2347–2357.
80.
FortierLSinklerMADe WittAJ, et al.The effects of opioid dependency use on postoperative spinal surgery outcomes: a review of the available literature. Anesth Pain Med2023; 13: e136563.
81.
GrayJCLarsonMJMorescoN, et al.Healthcare utilization and readiness outcomes among soldiers with post-deployment at-risk drinking, by multimorbidity class. Alcohol2024; 114: 31–39.
82.
HalickaMDuarteRCatherallS, et al.Systematic review and meta-analysis of predictors of return to work after spinal surgery for chronic low back and leg pain. J Pain2022; 23: 1318–1342.
83.
HeikkilaHRistmagiA. Effect of opioid use on results of interventional back pain management on patients with suspected face-mediated chronic back pain. Pain Physician2022; 25: E733–E738.
84.
JoveyRDBalonJMabeeJ, et al.Patients response to interventional care for chronic pain study (PRICS): a cross-sectional survey of community-based pain clinics in Ontario, Canada. Cureus2023; 15: e37440.
85.
KleinmannBWolterT. Opioid consumption in chronic pain patients: role of perceived injustice and other psychological and socioeconomic factors. J Clin Med2022; 11: 47.
86.
LjungvallHRhodinAWagnerS, et al.My life is under control with these medications”: an interpretative phenomenological analysis of managing chronic pain with opioids. BMC Musculoskelet Disord2020; 21: 61.
87.
NabiMHHawladerMDHNazF, et al.Low back pain among professional bus drivers: a cross-sectional study from Bangladesh. BMC Public Health2023; 23: 1172.
88.
Navarro-CompánVBaraliakosXMagreyM, et al.Effect of upadacitinib on disease activity, pain, fatigue, function, health-related quality of life and work productivity for biologic refractory ankylosing spondylitis. Rheumatol Ther2023; 10: 679–691.
89.
PerrotSDoaneMJJaffeDH, et al.Burden of chronic low back pain: association with pain severity and prescription medication use in five large European countries. Pain Pract2022; 22: 359–371.
90.
TeferaYGGraySNielsenS, et al.Impact of prescription medicines on work-related outcomes in workers with musculoskeletal disorders or injuries: a systematic scoping review. J Occup Rehabil2024; 34: 398–414.
91.
ThakkarSGiffordBSellH, et al.A retrospective cohort analysis of the impact of osteoarthritis on disability leave, Workers’ compensation claims, and healthcare payments. J Occup Environ Med2021; 63: e883–e892.
92.
UllmanCJHengstDRolfsonO, et al.Systematic review of injuries and chronic musculoskeletal pain among high-speed boat operators. Mil Med2024; 189: e573–e580.
93.
VervullensSBreugelmansLBeckersL, et al.Clinical prediction model for interdisciplinary biopsychosocial rehabilitation in osteoarthritis patients. Eur J Phys Rehabil Med2024; 60: 84–94.
94.
FriedliTGantschnigBE. The role of contextual factors on participation in the life area of work and employment after rehabilitation: a qualitative study on the views of persons with chronic pain. Work2022; 71: 119–132.
95.
SolarOIrwinA. A conceptual framework for action on the social determinants of health [internet]. Geneva: World Health Organisation, 2010, pp.1–76. Available from: https://www.who.int/publications/i/item/9789241500852 (cited 5 December 2024).
96.
BirkinshawHFriedrichCColeP, et al.Antidepressants for pain management in adults with chronic pain: a network meta-analysis. Cochrane Database Syst Rev2023; 5. 10.1002/14651858.CD014682.pub2
97.
FerraroMCashinAWandB, et al.Interventions for treating pain and disability in adults with complex regional pain syndrome- an overview of systematic reviews. Cochrane Database Syst Rev2023; 6. 10.1002/14651858.CD009416.pub3
98.
ElsCJacksonTHagtvedtR, et al.High-dose opioids for chronic non-cancer pain: an overview of cochrane reviews. Cochrane Database Syst Rev2023: 3. 10.1002/14651858.CD012299.pub3
99.
HigginsSASimonsJ. The opioid epidemic and the role of the occupational health nurse. Workplace Health Saf2019; 67: 36–45.
100.
AsfawAQuayBBushnellT, et al.Injuries that happen at work lead to more opioid prescriptions and higher opioid costs. J Occup Environ Med2022; 64: e823–e832.
101.
ShawWSRoelofsCPunnettL. Work environment factors and prevention of opioid-related deaths. Am J Public Health2020; 110: 1235–1241.
102.
KamperSJApeldoornATChiarottoA, , et al.Multidisciplinary biopsychosocial rehabilitation for chronic low back pain: Cochrane systematic review and meta-analysis. Br Med J. 2015;350. https://www.bmj.com/content/350/bmj.h444
103.
HovingJLLacailleDUrquhartDM, et al.Non-pharmacological interventions for preventing job loss in workers with inflammatory arthritis. Cochrane Database Syst Rev2014; 11: CD010208.
104.
SyMPBontjePOhshimaN, et al.Articulating the form, function, and meaning of drug using in the Philippines from the lens of morality and work ethics. J Occup Sci2020; 27: 12–21.
